Human fibroblast interferon in human neoplasia: clinical and laboratory study. 1978

J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter

Human fibroblast interferon (HFIF) produced on a large scale from normal diploid cell strains was highly purified and then evaluated as to its safety clinical investigation. The selective antiproliferative activity of HFIF was observed in vitro against certain human malignant cell lines and in vivo against human bladder tumors grown in nude mice. Direct injections of HFIF into metastatic melanoma lesions of two patients resulted in either the disappearance of malignant cells or the significant reduction in tumor volume.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
December 1991, Minerva ginecologica,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
May 1985, The Journal of reproductive medicine,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
January 1982, Cancer chemotherapy and pharmacology,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
January 1984, International journal of tissue reactions,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
May 1983, Gan no rinsho. Japan journal of cancer clinics,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
July 1975, Biochemical and biophysical research communications,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
January 1980, Pharmacology & therapeutics,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
April 1981, Nihon Gan Chiryo Gakkai shi,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
June 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
J S Horoszewicz, and S S Leong, and M Ito, and R F Buffett, and C Karakousis, and E Holyoke, and L Job, and J G Dölen, and W A Carter
January 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!